After treatment of patients with stage 3C1 cervical squamous carcinoma, the clinical five-year survival rate is often used as a criterion to judge the clinical cure rate, which is about 35%. Cervical squamous carcinoma is a common malignant tumor in women, caused by various factors such as gene mutation, HPV (human papillomavirus infection), and heredity. According to FIGO staging, 3C1 of squamous carcinoma of the cervix is a condition in which the tumor involves the lymph nodes in the pelvis, independent of the size and extent of the tumor. After diagnosis in this period, it is mostly treated by non-surgical therapies, such as radiotherapy and chemotherapy, etc. After active treatment, patients with stage 3C1 can obtain a five-year survival rate of about 35%. After surgery, patients can maintain good living habits and follow the doctor’s instructions for regular checkups, which can reduce recurrence to a certain extent.